Potentially inappropriate prescribing among older patients and associated factors
comparison of two versions of STOPP/START criteria
DOI:
https://doi.org/10.1590/s2175-97902023e22549Keywords:
Geriatrics, Health services for the aged, Potentially inappropriate medication list, Drug utilization, PrevalenceAbstract
The study aimed to estimate and compare the prevalence and type of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) between the STOPP/START original (v1) and updated version (v2) among older patients in various settings, as well as associated factors. The study included 440 patients attending a community pharmacy, 200 outpatients and 140 nursing home users. An increase in the prevalence of STOPP v2 (57.9%) compared to v1 (56.2%) was not statistically significant in the total sample and within each setting (p>0.05). A decrease in the prevalence of START v1 (55.8%) to v2 (41.2%) was statistically significant (p<0.001) in the total sample and within each setting (p<0.05). Drug indication (32.9%) and fall-risk medications (32.2%) were most commonly identified for STOPP v2, while cardiovascular system criteria (30.5%) were the most frequently detected for START v2. The number of medications was the strongest predictor for both STOPP v1 and v2, with odds ratio values of 1.35 and 1.34, respectively. Patients’ characteristics associated with the occurrence of STOPP and START criteria were identified. According to both STOPP/START versions, the results indicate a substantial rate of potentially inappropriate prescribing among elderly patients. The prevalence of PIMs was slightly higher with the updated version, while the prevalence of PPOs was significantly lower.
Downloads
References
American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2022. Diabetes care. 2022;45(Suppl 1):S144-S174.
Anrys PMS, Strauven GC, Foulon V, Degryse JM, Henrard S, Spinewine A. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018;19(10):884-890.
Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157(14):1531-1536.
Blanco-Reina E, Garcia-Merino MR, Ocana-Riola R, Aguilar-Cano L, Valdellos J, Bellido-Estevez I, et al. Assessing potentially inappropriate prescribing in community-dwelling older patients using the updated version of STOPP-START criteria: a comparison of profiles and prevalences with respect to the original version. PLoS One. 2016;11(12):e0167586.
Blanco-Reina E, Valdellos J, Aguilar-Cano L, Garcia-Merino MR, Ocana-Riola R, Ariza-Zafra G, et al. 2015 Beers criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: prevalence, profile, and risk factors. Eur J Clin Pharmacol. 2019;75(10):1459-1466.
Bo M, Gibello M, Brunetti E, Boietti E, Sappa M, Falcone Y, et al. Prevalence and predictors of inappropriate prescribing according to the Screening Tool of Older People’s Prescriptions and Screening Tool to Alert to Right Treatment version 2 criteria in older patients discharged from geriatric and internal medicine wards: a prospective observational multicenter study. Geriatr Gerontol Int. 2019;19(1):5-11.
Boland B, Guignard B, Dalleur O, Langgh PO. Application of STOPP/START and Beers criteria: compared analysis on identification and relevance of potentially inappropriate prescriptions. Eur Geriatr Med. 2016;7(5):416-423.
Buda V, Prelipcean A, Andor M, Dehelean L, Dalleur O, Buda S, et al. Potentially inappropriate prescriptions in ambulatory elderly patients living in rural areas of Romania using STOPP/START (version 2) criteria. Clin Interv Aging. 2020;15:407-417.
Conejos Miquel MD, Sanchez Cuervo M, Delgado Silveira E, Sevilla Machuca I, Gonzalez-Blazquez S, Montero Errasquin B, et al. Potentially inappropriate drug prescription in older subjects across health care settings. Eur Geriatr Med . 2010;1(1):9-14.
Counter D, Millar JWT, McLay JS. Hospital readmissions, mortality and potentially inappropriate prescribing: a retrospective study of older adults discharged from hospital. Br J Clin Pharmacol. 2018;84(8):1757-1763.
Curtin D, Gallagher PF, O’Mahony D. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf. 2019;10:2042098619829431.
Drenth-van Maanen AC, Wilting I, Jansen PAF. Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol . 2020;86(10):1921-1930.
Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Intervention with the Screening Tool of Older Persons potentially inappropriate Prescriptions/Screening Tool to Alert doctors to Right Treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc. 2014;62(9):1658-1665.
Gallagher P, Lang PO, Cherubini A, Topinkova E, Cruz-Jentoft A, Montero Errasquin B, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol . 2011a ;67(11):1175-1188.
Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72-83.
Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011b;89(6):845-854.
Garcia-Gollarte F, Baleriola-Julvez J, Ferrero-Lopez I, Cruz-Jentoft AJ. Inappropriate drug prescription at nursing home admission. J Am Med Dir Assoc . 2012;13(1):83.e9-15.
Gaubert-Dahan ML, Sebouai A, Tourid W, Fauvelle F, Aikpa R, Bonnet-Zamponi D. The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study. Ther Adv Drug Saf . 2019;10:2042098619855535.
Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171(11):1013-1019.
Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360-372.
Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS. Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/ Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther . 2016;41(2):158-169.
Hudhra K, Beci E, Petrela E, Xhafaj D, Garcia-Caballos M, Bueno-Cavanillas A. Prevalence and factors associated with potentially inappropriate prescriptions among older patients at hospital discharge. J Eval Clin Pract. 2016;22(5):707-713.
Kovacevic SV, Miljkovic B, Culafic M, Kovacevic M, Golubovic B, Jovanovic M, et al. Evaluation of drug-related problems in older polypharmacy primary care patients. J Eval Clin Pract . 2017a;23(4):860-865.
Kovacevic SV, Miljkovic B, Vucicevic K, Culafic M, Kovacevic M, Golubovic B, et al. Elderly polypharmacy patients’ needs and concerns regarding medication assessed using the structured patient-pharmacist consultation model. Patient Educ Couns. 2017b;100(9):1714-1719.
Ma Z, Tong Y, Zhang C, Liu L. Potentially inappropriate medications and potentially prescribing omissions in Chinese older patients: comparison of two versions of STOPP/START. J Clin Pharm Ther . 2020;45(6):1405-1413.
Montgomery S, Miedema MD, Dodson JA. Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults. Heart. 2022;108(14):1090-1097.
Nedin Rankovic G, Jankovic SM, Velickovic Radovanovic R, Jovic Z, Pesic G, Pavlovic S, et al. Potentially inappropriate prescribing of drugs in elderly patients on chronic hemodialysis treatment. Clin Nephrol. 2018;89(6):453-460.
O’Connor MN, O’Sullivan D, Gallagher PF, Eustace J, Byrne S, O’Mahony D. Prevention of hospital-acquired adverse drug reactions in older people using Screening Tool of Older Persons’ Prescriptions and Screening Tool to Alert to Right Treatment criteria: a cluster randomized controlled trial. J Am Geriatr Soc. 2016; 64(8): 1558-1566.
O’Mahony D. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020;13(1):15-22.
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015; 44(2): 213-218.
O’Mahony D, Gallagher P, Ryan C, Byrne S, Hamilton H, Barry P, et al. STOPP & START criteria: a new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med . 2010;1(1):45-51.
Pereira TFF, de Sa Soares A, Trevisol DJ, Schuelter-Trevisol F. Assessing the overall medication use by elderly people in a Brazilian hospital using the start/stopp criteria version 2. Braz J Pharm Sci. 2019;55:e17739.
Projovic I, Vukadinovic D, Milovanovic O, Jurisevic M, Pavlovic R, Jacovic S, et al. Risk factors for potentially inappropriate prescribing to older patients in primary care. Eur J Clin Pharmacol . 2016;72(1):93-107.
Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol . 2017;73(8):927-935.
Rogero-Blanco E, Lopez-Rodriguez JA, Sanz-Cuesta T, Aza-Pascual-Salcedo M, Bujalance-Zafra MJ, Cura-Gonzalez I, et al. Use of an electronic clinical decision support system in primary care to assess inappropriate polypharmacy in young seniors with multimorbidity: observational, descriptive, cross-sectional study. JMIR Med Inform. 2020;8(3):e14130.
Stojanovic M, Vukovic M, Jovanovic M, Dimitrijevic S, Radenkovic M. GheOP(3) S tool and START/STOPP criteria version 2 for screening of potentially inappropriate medications and omissions in nursing home residents. J Eval Clin Pract . 2020;26(1):158-164.
Thevelin S, Mounaouar LE, Marien S, Boland B, Henrard S, Dalleur O. Potentially inappropriate prescribing and related hospital admissions in geriatric patients: a comparative analysis between the STOPP and START criteria versions 1 and 2. Drugs Aging. 2019;36(5):453-459.
Thomas RE, Thomas BC. A systematic review of studies of the STOPP/START 2015 and American geriatric society Beers 2015 criteria in patients ≥ 65 years. Curr Aging Sci. 2019;12(2):121-154.
Vezmar Kovacevic S, Simisic M, Stojkov Rudinski S, Culafic M, Vucicevic K, Prostran M, et al. Potentially inappropriate prescribing in older primary care patients. PLoS One . 2014;9(4):e95536.
Zazzara MB, Palmer K, Vetrano DL, Carfi A, Onder G. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med . 2021;12(3):463-473.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
